Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Change in Cash (2020 - 2025)

Historic Change in Cash for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to -$2.4 million.

  • Quipt Home Medical's Change in Cash fell 22821.58% to -$2.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.7 million, marking a year-over-year decrease of 28111.2%. This contributed to the annual value of -$3.0 million for FY2025, which is 17905.47% down from last year.
  • As of Q4 2025, Quipt Home Medical's Change in Cash stood at -$2.4 million, which was down 22821.58% from $1.9 million recorded in Q3 2025.
  • In the past 5 years, Quipt Home Medical's Change in Cash registered a high of $3.4 million during Q2 2021, and its lowest value of -$12.6 million during Q1 2022.
  • Over the past 5 years, Quipt Home Medical's median Change in Cash value was -$358000.0 (recorded in 2021), while the average stood at -$1.3 million.
  • Its Change in Cash has fluctuated over the past 5 years, first crashed by 47926.57% in 2022, then soared by 15164.47% in 2024.
  • Over the past 5 years, Quipt Home Medical's Change in Cash (Quarter) stood at -$4.5 million in 2021, then dropped by 7.1% to -$4.9 million in 2022, then surged by 122.98% to $1.1 million in 2023, then crashed by 164.73% to -$723000.0 in 2024, then plummeted by 228.22% to -$2.4 million in 2025.
  • Its Change in Cash was -$2.4 million in Q4 2025, compared to $1.9 million in Q3 2025 and -$5.9 million in Q2 2025.